BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11434418)

  • 21. Size and burden of mental disorders in Europe--a critical review and appraisal of 27 studies.
    Wittchen HU; Jacobi F
    Eur Neuropsychopharmacol; 2005 Aug; 15(4):357-76. PubMed ID: 15961293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and impact of comorbid anxiety and bipolar disorder.
    Keller MB
    J Clin Psychiatry; 2006; 67 Suppl 1():5-7. PubMed ID: 16426110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescribing patterns for depression and anxiety worldwide.
    Lecrubier Y
    J Clin Psychiatry; 2001; 62 Suppl 13():31-6; discussion 37-8. PubMed ID: 11434416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacotherapy of comorbid mood, anxiety, and substance use disorders.
    Brady KT; Verduin ML
    Subst Use Misuse; 2005; 40(13-14):2021-41, 2043-8. PubMed ID: 16282091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationships among pain, anxiety, and depression in primary care.
    Means-Christensen AJ; Roy-Byrne PP; Sherbourne CD; Craske MG; Stein MB
    Depress Anxiety; 2008; 25(7):593-600. PubMed ID: 17932958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder.
    Goldstein BI; Levitt AJ
    Bipolar Disord; 2008 Feb; 10(1):67-78. PubMed ID: 18199243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Public health perspectives on generalized anxiety disorder.
    Stein MB
    J Clin Psychiatry; 2004; 65 Suppl 13():3-7. PubMed ID: 15384930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the link between anxiety symptoms and suicidal ideation and behaviors in outpatients with bipolar disorder.
    Simon NM; Pollack MH; Ostacher MJ; Zalta AK; Chow CW; Fischmann D; Demopulos CM; Nierenberg AA; Otto MW
    J Affect Disord; 2007 Jan; 97(1-3):91-9. PubMed ID: 16820212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comorbidity in generalized anxiety disorder: impact and implications.
    Stein DJ
    J Clin Psychiatry; 2001; 62 Suppl 11():29-34; discussion 35-6. PubMed ID: 11414548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and burden of general medical conditions among adults with bipolar I disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Perron BE; Howard MO; Nienhuis JK; Bauer MS; Woodward AT; Kilbourne AM
    J Clin Psychiatry; 2009 Oct; 70(10):1407-15. PubMed ID: 19906344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of comorbid substance use disorders on treatment outcome for anxiety disorders.
    McEvoy PM; Shand F
    J Anxiety Disord; 2008 Aug; 22(6):1087-98. PubMed ID: 18164585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consensus statement on the benefit to the community of ESEMeD (European Study of the Epidemiology of Mental Disorders) survey data on depression and anxiety.
    Nutt DJ; Kessler RC; Alonso J; Benbow A; Lecrubier Y; Lépine JP; Mechanic D; Tylee A
    J Clin Psychiatry; 2007; 68 Suppl 2():42-8. PubMed ID: 17288507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generalized anxiety disorder: prevalence, burden, and cost to society.
    Wittchen HU
    Depress Anxiety; 2002; 16(4):162-71. PubMed ID: 12497648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.
    Melartin TK; Rytsälä HJ; Leskelä US; Lestelä-Mielonen PS; Sokero TP; Isometsä ET
    J Clin Psychiatry; 2002 Feb; 63(2):126-34. PubMed ID: 11874213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-fearful vs. fearful panic attacks: a general population study from the National Comorbidity Survey.
    Chen J; Tsuchiya M; Kawakami N; Furukawa TA
    J Affect Disord; 2009 Jan; 112(1-3):273-8. PubMed ID: 18534684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comorbidity in primary care: presentation and consequences.
    Wittchen HU; Lieb R; Wunderlich U; Schuster P
    J Clin Psychiatry; 1999; 60 Suppl 7():29-36; discussion 37-8. PubMed ID: 10326872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Social anxiety disorder: an unrecognized problem in primary care.
    Katzelnick DJ; Greist JH
    J Clin Psychiatry; 2001; 62 Suppl 1():11-5; discussion 15-6. PubMed ID: 11206029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Social phobia in Finnish general adolescent population: prevalence, comorbidity, individual and family correlates, and service use.
    Ranta K; Kaltiala-Heino R; Rantanen P; Marttunen M
    Depress Anxiety; 2009; 26(6):528-36. PubMed ID: 19170089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary care perspectives on generalized anxiety disorder.
    Roy-Byrne PP; Wagner A
    J Clin Psychiatry; 2004; 65 Suppl 13():20-6. PubMed ID: 15384933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consensus statement on transcultural issues in depression and anxiety from the International Consensus Group on Depression and Anxiety.
    Ballenger JC; Davidson JR; Lecrubier Y; Nutt DJ; Kirmayer LJ; Lépine JP; Lin KM; Tajima O; Ono Y
    J Clin Psychiatry; 2001; 62 Suppl 13():47-55. PubMed ID: 11434419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.